论文部分内容阅读
接近2万元/克的野山参是非常罕见的,囤积8000多克人参会占用大量资金,这对现金流早已恶化的紫鑫药业是个更大的危险。这显然是个刀口舔血的生意。近日,中国卫生部正式批准人工种植人参为新资源食品,这对已经囤积了大量人参的紫鑫药业来说,可谓是个天大的好消息,随后,紫鑫药业股价大涨。但股价大涨难掩紫鑫药业的冒险行为。
Wild ginseng close to 20,000 yuan / g is very rare, hoarding more than 8000 grams of ginseng will occupy a lot of money, which has deteriorated the flow of cash purple Xin Pharmaceutical is a greater danger. This is obviously a knife-licking blood business. Recently, the Chinese Ministry of Health officially approved the artificial cultivation of ginseng as a new source of food, which has accumulated a large number of ginseng purple Xin Pharmaceutical can be described as a big good news, then, purple Xin Pharmaceutical shares soared. However, the stock price surge conceal Purple Xin Pharmaceutical risk-taking behavior.